TACSTD2

TACSTD2
Identifiers
AliasesTACSTD2, EGP-1, EGP1, GA733-1, GA7331, GP50, M1S1, TROP2, tumor-associated calcium signal transducer 2, tumor associated calcium signal transducer 2
External IDsOMIM: 137290; MGI: 1861606; GeneCards: TACSTD2
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

4070

56753

Ensembl

ENSG00000184292

ENSMUSG00000051397

UniProt

P09758

Q8BGV3

RefSeq (mRNA)

NM_002353

NM_020047

RefSeq (protein)

NP_002344

NP_064431

Location (UCSC)Chr 1: 58.58 – 58.58 MbChr 6: 67.51 – 67.51 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Tumor-associated calcium signal transducer 2 (Trop-2) is a protein that is encoded by the TACSTD2 gene. The protein was identified via the monoclonal antibody GA733 (giving the name GA733-1). It was separately characterized as an epithelial cell-surface antigen (EGP-1) that was later recognized as a calcium signal transducer (TACSTD2/Trop-2).

This intronless gene is located at the short arm of chromosome 1 (1p32.1). It encodes a carcinoma-associated antigen that is closely related to epithelial cell adhesion molecule (EpCAM/TACSTD1). It transduces an intracellular calcium signal and acts as a cell surface receptor.

It is expressed in low levels in normal epithelia but is overexpressed in the membranes of many epithelial-derived cancers, including breast (especially triple-negative breast cancer), lung, gastric, colorectal, pancreatic, and ovarian, cancers. High expression of TACSTD2 in cancer drives proliferation and is associated with worse outcomes. Mutations of this gene result in gelatinous drop-like corneal dystrophy, an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness.